COVID-19 Updates
From the Journals
What do early remdesivir data suggest?
Data are ‘almost uninterpretable,’ says one drug researcher.
From the Journals
Remdesivir tops list of promising COVID-19 treatments in review of nearly 300 trials
Hydroxychloroquine data have “major limitations,” and corticosteroids are not recommended for supportive care.
From the Journals
Troponins touted as ‘ally’ in COVID-19 triage, but message is nuanced
A consequence of not measuring hs-cTn may be to “ignore the plethora of ischemic and nonischemic causes of myocardial injury related to COVID-19...
Commentary
COVID-19 pandemic brings unexpected pediatric consequences
Feature
ASH tackles COVID-19 with hematology-related FAQ, promotes new registries
From the Journals
Managing gynecologic cancers during the COVID-19 pandemic
Doctors provide guidance and discuss their experiences managing patients with gynecologic cancers during these challenging times.
Latest News
ABIM grants MOC extension
Those in their grace year will also be afforded an additional grace year in 2021.
Opinion
COVID 19: Confessions of an outpatient psychiatrist during the pandemic
It seems that some glitches would be inevitable. With a sudden shift to videoconferencing in private psychiatric practices, there were bound to be...
Feature
ASCO announces its own COVID-19 and cancer registry
ASCO aims to learn how COVID-19 is impacting cancer patients’ treatment and outcomes.
From the Journals
Treating rectal cancer in the COVID-19 era: Expert guidance
Experts recommend total mesorectal excision for early- and intermediate-stage disease and a short course of preoperative radiotherapy for locally...
Latest News
Presymptomatic or asymptomatic? ID experts on shifting terminology
They also discussed the growing realization of racial disparities in COVID-19.